Topic Listing for CryoLife

Acceptance Products Accounting Payments
Accounting Treatment Accrued Procurement Fees
Accumulated Other Comprehensive Loss Actions Regulatory Authorities
Additional Bonus Related Adjusted Net Income Additional Information Visit Cryolifes Web Site
Additional Performance-based Bonus Additional Regulatory Approvals
Additional Terms Conditions Restricted Stock Award Adjusted Net Income
Adjusted Net Income 15608000 Adjusted Revenues
Adjusted Revenues 101764000 Adjusted Revenues 2009 Cardiac Vascular Allograft Tissue Processing
Administration 2009 Employee Stock Incentive Plan Administration Calculation Claims Final Awards Supervision Distribution Settlement
Administration Plan Admission Ticket Only
Admission Wrongdoing Adverse Publicity Reduce Demand Products Services Not Affected
Advertising Costs Affiliates8221
Affirmative Covenants Agency
Agreement Bioform Medical Inc Agreement Cleveland Clinic Develop Aortic Mitral Allograft
Agreement Not Solicit Agreements Releases
Albert Heacox Phd Albert Heacox Phd Senior Vice President Research Development
Amendment Amendment Credit Agreement
Amendment Employment Agreement Amendment Termination
Amendments Articles Incorporation Bylaws Change Amendments Bylaws
Amendments Waivers Amy Horton Cpa
Analysis Analysis Total Compensation
Anderson Anderson Entitled Receive Personal Life Insurance Amount Not
Annual Grants Annual Meeting 2007
Annual Meeting 2008 Annual Meeting Admission
Annual Meeting Stockholders Annual Minimums
Annual Performance-based Bonus Annual Retainer Committee Chair Fees
Anti-takeover Provisions Discourage Make Difficult Attempt Obtain Control Anticipated Improvement Bioglue Revenues Continuation Favorable Trends Tissue
Antitrust Law Compliance Appendix
Applicable Laws8221 Approval Cryolife Inc 2009 Employee Stock Incentive Plan
Arrangement Gerald Seery Effective 2006 Ashley Lee Cpa
Ashley Lee Gerald Seery Assignments Participations Successors
Assistance Orton Reporting Atlanta 2010 Cryolife Inc Nyse Cry
Atlanta Ga133 2006 133 Cryolife Inc Nyse Cry Audit Committee
Audit Committees Pre-approval Policies Procedures Authority
Automatic Conversion Preferred Stock Availability Corporate Governance Documents
Available Information Awards
Awards Employees Subject Taxation Outside United States Background
Backlog Balance Page Intentionally Left Blank Signature Follows
Base Salary Based Actual Adjusted Net Income 10484000
Basic Terms Change Control Agreement Basis Presentation
Bellows Applicator8221 Beneficial Ownership Reporting Compliance
Binding Assignment Bioadhesive Bioprosthetic Manufacturing
Biofoam Bioglue
Bioglue Biofoam Bioglue Brow Lift Approval
Bioglue Related Products Bioglue Surgical Adhesive
Bioprosthetic Cardiac Vascular Devices Bioprosthetic Cardiovascular Devices
Bioprosthetic Cardiovascular Vascular Devices Board Adopted Written Policies Procedures Review Approval Ratification
Board Committee Meetings Bonus Agreement
Bonus Named Executive Officer Earn Percentage His Base Bonus Plan
Bonus Plan Program Bonus Program
Borrowing Procedures Settlements Branding
Bruce Anderson Business Day8221
Capital Expenditures Cardiac Preservation Services
Cardiovascular Preservation Services Cardiowrap Distribution Agreement
Cash Bonuses Cash Equivalents
Cash Equivalents Marketable Securities Certain Beneficial Ownership
Certain Interests Directors Certain Reclassifications Prior Amounts
Certain Relationships Related Transactions Certain Transactions
Certification Pursuant Certification Pursuant Usc 1350 Adopted 906 Sarbanes-oxley Act
Certifications Change Control
Change Control Agreements Change Labeling
Change-in-control Claims Lead Plaintiffs Benefits Settlement
Class Action Lawsuit Code
Code Business Conduct Ethics Combined Obligations
Commercially Reasonable Efforts8221 Commitments Contingencies
Common Stock Common Stock Dividends Not Likely Paid Foreseeable Future
Communication Board Directors Committees Compared 2004
Compared 2006 Compared 2007
Compensation Basic Terms Employment Compensation Benefits Business Expenses
Compensation Chief Executive Officer Compensation Committee Interlocks Insider Participation
Compensation Committee Report Compensation Philosophy Objectives
Compensation Surveys Competition
Competition Fair Dealing Compliance
Compliance 409a Compliance Laws
Compliance Training Program Comprehensive Income
Comprehensive Income Loss Conclusion
Conditions Precedent Conditions Settlement Effect Disapproval Cancellation Termination
Confidential Information Confidential Treatment Requested
Confidentiality Conflicts Interest
Consent Independent Registered Public Accounting Firm Consolidation Healthcare Industry Lead Demands Price Concessions Limits
Continue Feel Adverse Impacts Fda Order Subsequent Activity Contractual Commitments
Controls Procedures Convertible Preferred Stock
Corporate Governance Management Corporate Opportunities
Cost Human Tissue Preservation Services Cost Preservation Services
Cost Products Costs Expenses
Counterparts Covenant Capital Expenditure Limit
Covenant Leverage Ratio Credit Agreement
Credit Facility Credit Facility Expired 2008 Ability Pursue Significant Acquisitions
Credit Facility Limits Ability Pursue Significant Acquisitions Critical Accounting Policies
Cryolife Agreements Cryolife Dependent Key Personnel
Cryolife Inc Cryolife Inc 1655 Roberts Boulevard Kennesaw Georgia 30144
Cryolife Inc 2008 Non-employee Directors Omnibus Stock Plan Cryolife Inc Form 10-q 2005 Index
Cryolife Inc Proxy Solicited Behalf Board Directors Annual Cryolife Inc Subsidiaries
Cryolife Inc Subsidiaries Valuation Qualifying Accounts 2005 2004 Cryolife Marks8221
Cryolife Not Able Pay Cash Dividends Capital Stock Cryolife Not Successful Expanding Business Activities International Markets
Cryolife Not Successful Obtaining Necessary Clinical Results Regulatory Cryolife Receives American Association Tissue Banks Aatb Accreditation
Cryolife Restricted Stock Award Agreement Cryolife Subject Ongoing Sec Investigation
Cryolife Unable Address Concerns Raised Fda Form 483 Cryolifes Independent Registered Public Accounting Firm
Cryolifes Insurance Coverage Been Either Unavailable Insufficient Cryolifes Products Tissues Processes Allegedly Caused Future Cause
Cryolifes Proposed Acquisition Medafor Poses Number Risks Cryopatch Pulmonary Cardiac Patch
Cryopatch Pulmonary Cardiac Patch Shelf Life Cryopreserved Human Tissues Bioprosthetic Cardiovascular Devices
Cryovalve Aortic Heart Valve Cryovalve Pulmonary Heart Valve Post-clearance Study Not Provide
Cryovalve Pulmonary Human Heart Valve Post-clearance Study Not Cryovalve Sgpv Post-clearance Study Not Provide Expected Results
Current Economic Conditions Impact Demand Products Tissues Current Future Economic Credit Crisis Adversely Affect Business
Date Report Earliest Event Reported 2005 David Ashley Lee Executive Vice President Chief Operating
David Fronk David Fronk Vice President Regulatory Affairs Quality Assurance
David Hollinworth Phd Death
Debt Defendants Denials Wrongdoing Liability
Deferred Compensation Deferred Income Taxes
Deferred Preservation Costs Definition Adhesive
Definitions Definitions Construction
Demand Tissues Products Decrease Future Material Adverse Effect Department Defense Hospitals8221
Departure Directors Certain Officers Election Appointment Compensatory Arrangements Dependent Availability Sufficient Quantities Tissue Human Donors
Dependent Key Personnel Derivative
Derivative Instruments Derivative Settlement Regarding Director Compensation
Derivative Valuation Risk Derivatives
Description Cryolife Inc 2006 Performance-based Bonus Plan Description Cryolife Inc Performance-based Bonus Plan
Director Compensation Director Independence
Directors Executive Officers Registrant Directors Stock Option Agreement Grant
Disability Distribution Grant Revenues
Dividend Equivalent Rights Dividend Make Whole Payments
Dividend Make-whole Payments Documents Incorporated Reference
Due Authorization Conflict Due Organization Qualification Subsidiaries
Earnings Earnings Loss Per Common Share
Earnings Loss Per Share Earnings Per Share
Effect Termination Effective Date Term Plan
Election Directors Elements Compensation Program
Elements Director Compensation Elements Non-employee Director Compensation
Eligibility Participation Employee Benefit Plans
Employee Resides Following Address Employee Stock Incentive Plan
Employees Employees Representations Warranties Execution Agreement Employee Represents Warrants
Employment Employment Agreement
Employment Agreement Gerald Seery Employment Agreements
Employment Change Control Agreements Employment Duties
Entire Agreement Amendments Environmental Matters
Equal Opportunity Equity Compensation Plan Information
Equity Grant Policy Equity Incentives
Escrow Agent Estimates
Ethics Compliance Board Europa
European Operations Events
Events Default Exact Name Registrant Specified Charter
Except Extent Provided Neither Party Shall Liable Other Exchange Service Agreement
Exchange Service Agreement Rti Exclusive Distribution Rights
Executive Compensation Executive Incentive Plan
Executive Insurance Plan Executive Officers Registrant
Exercise Options Sars Exhibits
Exhibits Schedules Existing Insurance Policies Not Sufficient Cover Actual Claims
Expatriate Tax Payment Expenses
Experienced Operating Losses Negative Cash Flow Address Underlying Experienced Operating Losses Negative Cash Flows Continue Address
Expiration Employment Agreement Extensive Government Regulation Adversely Affect Ability Develop Market
Extensive Government Regulation Adversely Affect Ability Develop Sell Failure Adequately Comply Government Regulations Result Loss Revenues
Fair Values Financial Instruments Fda Correspondence
Fda Correspondence Notices Fda Inspection
Fda Notified Belief Marketing Cryovalve Cryovein Require Additional Fda Notified Cryolife Belief Marketing Cryovalve Cryovein Require
Fda Order Fda Order Human Tissue Preservation
Fda Order Human Tissue Preservation Other Correspondence Notices Fda Order Subsequent Activity
Fda Order Subsequent Activity Continue Adversely Impact Cryolifes Fda Previously Issued Recall Certain Products Ability Inspect
Fda8221 Federal Income Tax Consequences
Federal Regulation Human Tissue Federal Regulation Medical Devices
Fees Paid Independent Registered Public Accounting Firm Field Action8221
Field Actions Field8221
Financial Covenants Financial Credit Liquidity Crisis Adversely Affect Ability Borrow
Financial Guidance Financial Records Sec Filings Public Communications
Financial Statements Exhibits Financial Statements Exhibits 901
Financial Statements Supplementary Data Firm Orders
Force Majeure Forecasts
Foreign Approval Requirements Foreign Currency Exchange Rate Risk
Form 10-k Form 10-q
Form Directors Stock Option Agreement Grant Former Name Address Changed Since Last Report
Forms Estoppel Letter Forward Looking Statements
Forward-looking Statements Fraudulent Transfer
Full Settlement Funding Act Technology Not Available
Further Actions Future Health Care Reimbursement Methods Policies Affect Availability
Gain Exit Activities General
General Administrative Marketing Expenses General Information
General Provisions Gerald Seery
Gerald Seery Senior Vice President Sales Marketing Golden Parachute Tax 280g Internal Revenue Code
Government Regulation Governmental Authority8221
Grant Revenues Grants
Guidance Hand Delivery
Hazardous Materials Heacox Fronk
Headings Headings Captions
Healthcare Policy Changes Including Pending Proposals Reform System Hemostase
Householding Human Tissue Preservation Distribution
Human Tissue Processing Immediate Release
Impairments Long-lived Assets Implantable Biomaterials Surgical Adhesives Sealants
Implantable Biomedical Devices Surgical Adhesives Sealants Important
Important Proxies Returned Promptly Stockholders Not Expect Attend Income Loss Per Common Share
Income Per Common Share Income Taxes
Increasingly Dependent Revenues Bioglue Subject Variety Risks Affecting Index
Information Board Directors Infringement Notification
Initial Peer Group Companies Initial Peer Group Surveys
Insolvency Event8221 Inspections
Insurance Coverage Difficult Impossible Obtain Future Obtained Cost Insurance Coverage Dispute
Insurance Mediation Request Intangible Assets
Intellectual Property Information Ideas Intellectual Property8221
Intense Competition Affect Ability Operate Profitably Intense Competition Affect Cryolifes Ability Recover Fda Order
Intense Competition Affects Cryolifes Ability Recover Fda Order Intentionally Omitted
Interest Rate Risk Interest Rate Swap Agreement
International Approval Requirements Introduction
Inventories Inventory Cost8221
Inventory Repurchases Investments New Technologies Acquisitions Products Distribution Rights Not
Investments New Technologies Distribution Rights Not Successful Irs Circular 230 Notice
Issuer Purchases Equity Securities Jeffrey Burris Esq
Jointly Prepared Jurisdictions Rti Entities
Key Growth Strategies Identified Result Strategic Review Not Key Growth Strategies Not Generate Anticipated Benefits
Key Terms 2009 Employee Stock Incentive Plan Landlord Acknowledgment
Lawsuit Filed Against Medafor Regarding Distribution Agreement Adversely Leases
Legal Action Legal Compliance
Legal Description Premises Legal Proceedings
Lenders Rights Remedies Liability Claims
License Life Insurance
Limitation Limitation Expansion Benefits
Limitation Liability Limitation Termination Payments
Limitations Net Operating Loss Carryforwards Limitations Severance Separation Benefit Payments
Liquidity Capital Resources List Exhibits Included
Litigation Claims Assessments Long-lived Assets
Loss Per Share Loss Sole-source Suppliers Adverse Effect Revenues Financial Condition
Managements Report Internal Control Over Financial Reporting Sarbanes-oxley Managements Report Internal Controls Over Financial Reporting Sarbanes-oxley
Manufacturing Manufacturing Operations
Market Price Common Stock Marketable Securities
Marketable Securities Other Investments Marketing Approval8221
Marketing Approvals Marketing Sales Activities
Medafor Medafor Common Stock
Medafor Derivative Medafor Future Attempt Terminate Distribution Agreement Hinder Hemostase
Medafor License Agreement Medafors Notices Termination
Media Contacts Medical Device Manufacturing
Medical Devices Memorandum Lease
Messrs Anderson Lee Seery Messrs Lee Seery
Miscellaneous Miscellaneous Provisions
Mph Product8221 Name Person Filing Proxy Statement Other Registrant
Nature Business Negative Covenants
Net Cash Financing Activities Net Cash Investing Activities
Net Cash Operating Activities Net Income 10484000
Net Working Capital New Accounting Pronouncements
New Plan Benefits New Revolving Credit Facility Imposes Restrictions Ability Borrow
Non-compete Commitment Non-employee Directors
Non-exclusivity Rights Not Applicable
Not Insured Against Potential Losses Natural Disasters Other Not Likely Pay Common Stock Dividends Foreseeable Future
Not Paid Cash Dividends Capital Stock Unable Due Not Successful Expanding Business Activities International Markets Able
Not Successful Expanding Business Activities International Markets Unable Not Successful Obtaining Necessary Clinical Results Regulatory Approvals
Nota Regulation Notice Order Settlement Hearing
Notices Number 1-13165
Obligations Cryolife Termination Obligations Termination
Off-balance Sheet Arrangements Officers Performance Rating
Option Awards Option Exercise Price Vesting Awards
Option Exercises Stock Vested Option Grants
Option Restricted Stock Grants Named Executive Officers Options
Orthopaedic Preservation Services Other
Other Costs Expenses Other Events
Other Facilities Other Fda Correspondence Notices
Other Implantable Medical Devices Other Income Expenses
Other Litigation Other Medical Devices
Other Products Other Revenues
Other Rights Overall Liquidity Capital Resources
Overall Standard Overview
Part Partial Illegality
Party Rights Past Experienced Operating Losses Negative Cash Flows Continue
Patent Enforcement Patent Prosecution
Patents Licenses Other Proprietary Rights Payment Gratuities
Payment Obligations Payment Terms
Peer Group Benchmarking Peer Group Companies
Pension Benefits Percentage Base Salary
Performance Measures Performance Rating
Perquisites Personal Performance
Personal Performance Bonus Named Executive Officer Earn Percentage Physicians Been Continue Reluctant Implant Cryolifes Preserved Tissues
Physicians Been Continue Reluctant Implant Preserved Tissues Other Plaintiffs Counsels Attorneys Fees Reimbursement Expenses
Plan-based Awards Please Detach Mail Envelope Provided
Please Sign Below Show Accept Stock Award After Policies Procedures Review Approval Ratification Transactions Related Parties
Policies Procedures Stockholders Wish Submit Nominations Recommendations Board Policy Procedures Stockholders Submitting Names Candidates Election Board
Political Contributions Possible Other Fda Regulation
Post-employment Medical Plan Steven Anderson Post-market Clinical Studies
Post-retirement Medical Plan Steven Anderson Potential Adjusted Revenue Bonus Payouts 2008 Program
Potential Adjusted Revenue Bonus Payouts 2009 Program Potential Damages
Potential Payments Termination Change Control Potential Payments Termination Change-in-control
Preamble Preferred Derivative
Preferred Stock Preservation Services
Preservation Services Products Preserved Human Tissues Bioprosthetic Cardiac Vascular Devices
Presiding Director Pricing Approval8221
Primary Cash Requirements 2009 Arose Out General Working Principal Accounting Fees Services
Principles Consolidation Prior Amounts
Prior Period Adjustment Private Equity Placement
Procedural History Processing Manufacturing Operations
Procurement Distribution Marketing Procurement Sales Distribution Marketing
Product Applicator8221 Product Complaint8221
Product Complaints Reports Product Liability Claims
Product Warranty Products
Products Development Never Generate Significant Revenues Income Products Preservation Services
Products Tissues Process Allegedly Caused Future Cause Injury Properties
Property Equipment Protection Proper Cryolifes Assets
Provided Further Provided However
Proxy Biomedical Distribution Agreement Proxy Statement Annual Meeting Stockholders
Proxy Voting Instructions Purpose 2009 Employee Stock Incentive Plan
Purpose Eligibility Quality Assurance
Quantitative Qualitative Disclosures Market Risk Quarterly Plan Seery
Raises Revenue Guidance Rapid Technological Change Cause Services Products Become Obsolete
Receipt Payments Gifts Receive Form 483 Notice Observations Fda Unable Address
Receive Form 483 Notice Observations Warning Letter Other Recent Events
Recitals Recommendation Board Directors
Recommendations Board Directors Refusal Enter Discussions Hurts Medafor Shareholders
Registrant8217s Business Operations Registrants Telephone Number Including Area Code 770 419-3355
Regulation Regulatory Action Outside Affected Business Past Affect Future
Regulatory Action Outside Affected Business Past Also Affect Regulatory Action Outside Affected Cryolifes Business Past Also
Regulatory Audit Regulatory Authority8221
Regulatory Laws8221 Regulatory Patent Responsibilities
Releases Report Audit Committee
Report Independent Registered Public Accounting Firm Reporting Violations Code
Representations Representations Warranties Cryolife
Representations Warranties Rti Entities Required Vote
Research Development Research Development Clinical
Research Development Expenses Restricted Stock
Restricted Stock Grants Restricted Stock Units
Restricted Stock Units Performance Shares Results Operations Financial Condition
Retirement Retirement Event Employees Employment Terminates Reason Normal Early
Retirement Severance Benefit Revenue Orthopaedic Tissue Preservation Services Not Return Acceptable
Revenue Recognition Revenues
Revenues 89014000 Revenues Tables
Review Ongoing Transactions Review Potential Strategies Not Productive Outcome Process Uncertain
Revised Peer Group Companies Revised Peer Group Surveys
Revolver Advances Revolving Credit Facility Imposes Restrictions Ability Borrow Make
Richard Gridley Rights Assets Transfer
Risk Factors Risks Related Common Stock
Risks Uncertainties Roberts Boulevard Kennesaw 30144
Roberts Boulevard Kennesaw Georgia 30144 Rti Agreement
Rti Agreement Not Generate Anticipated Benefits Rti Agreements
Salary Sample Products
Sarbanes-oxley Act 2002 Satisfactory Levels Insurance Coverage Difficult Impossible Obtain Future
Schedule Schedule 14a
Schedule Base Rent Payments Schedule Estoppel Letter
Scheduled Contractual Obligations Future Payment Scheduled Contractual Obligations Future Payments
Schedules Scott Capps
Seasonality Sec Investigation
Sections 280g 4999 Securities Authorized Issuance Equity Compensation Plans
Securities Prices Cryolife Shares Been Continue Volatile Securities Registered Pursuant Act
Securities Trading Markets Security Ownership Certain Beneficial Owners Management
Set Off Settlement Agreement Release
Severability Severance Change-in-control Benefits
Severance Payment Procedure Severance Retirement Change-in-control Benefits
Shareholder Derivative Action Shareholder Rights Plan
Shares Reserved Plan Shares Subject 2009 Employee Stock Incentive Plan
Shipping Handling Charges Signatures
Significantly Dependent Revenues Bioglue Subject Variety Risks Affecting Sixth Amendment Lease
Special Limitations Isos Specifications8221
Standards Applied Persons Responsible Approving Related Party Transactions Standing Committees Board Directors
State Incorporation Location Chief Executive Office Organizational Identification State Licensing Requirements
Steven Anderson Steven Anderson Chairman Board Directors President Chief Executive
Stipulation Settlement Stock Appreciation Rights
Stock Appreciation Rights Sars Stock Awards
Stock Compensation Stock Compensation Expense
Stock Grants Stock Offerings Repurchases
Stock Option Agreement Grant Stock Option Awards
Stock Option Exercise Detail Stock Option Grant Policy
Stock Options Stock Ownership Guidelines
Stock Repurchase Stock Repurchases
Stock-based Compensation Stock-based Incentives
Stockholder Derivative Action Stockholder Proposals
Stockholders Cryolife Inc Strategy
Subject Sec Investigation Subject Stringent Domestic Foreign Regulation Impede Approval Process
Submission Matters Vote Security Holders Subsequent Events
Subsidiaries Cryolife Inc Success Tissues Products Depends Strong Relationships Physicians
Successors Summary Current Federal Income Tax Rates Individuals
Suppliers Sources Availability Tissues Raw Materials Surgical Adhesives Sealants Hemostats
Synergraft Synergraft Post-clearance Study Not Provide Expected Results
Synergraft Processed Human Pulmonary Heart Valve 510 Clearance Synergraft Processed Human Pulmonary Heart Valves Other Products
Synergraft Processed Human Pulmonary Heart Valves Shelf Life Synergraft Processed Pulmonary Heart Valves Not Accepted Marketplace
Synergraft Processed Pulmonary Heart Valves Shipped Implanted Within Synergraft Processed Tissues Not Demonstrate Expected Benefits
Tables Tax Gross-up Payment
Tax Impact Compensation Decisions Tax Rent
Tax Withholding Taxes
Taxes Expenses Technology License
Tenant Tenant Acknowledgment
Tenaxis Term 2009 Employee Stock Incentive Plan
Termination Termination Anderson Good Reason Cryolife Other Cause Death
Termination Cause Termination Employment
Termination Fronk Good Reason Cryolife Other Cause Death Termination Heacox Good Reason Cryolife Other Cause Death
Termination Lee Good Reason Cryolife Other Cause Death Termination Material Definitive Agreement
Termination Options Sars Termination Seery Good Reason Cryolife Other Cause Death
Termination Service Termination Supplemental Retirement Plan
Terms 1998 Long-term Incentive Plan Awards Terms 2004 Employee Stock Incentive Plan Awards
Terms Defined Terms Employment
Terms Stipulation Agreement Settlement Territory8221
Time Exercise Option Timothy Neja
Tissue Preservation Services Tissue Processing
Tissues Process Products Allegedly Caused Future Cause Injury Total Compensation
Traceability Trademarks
Trademarks8221 Trading Prices Common Stock Securities Biotechnology Companies General
Trading Prices Securities Been Continue Volatile Transaction Other Business
Transactions Related Parties Transferability Awards
Translation Foreign Currencies Trophic Solutions License Agreement
Types Transactions Covered Unable Address Causes Operating Losses Negative Cash Flows
Unable Address Concerns Raised Fda Form 483 Notices Unable Comply Covenants Credit Facility Limit Borrowing Capacity
Unable Fund Act Technology Unable Obtain Adequate Insurance Reasonable Cost
Unable Successfully Market Hemostase Unable Successfully Market Hemostase Mph
Uncertain Tax Positions Uncertainties Regarding Future Health Care Reimbursement Affect Amount
Uncertainties Related Patents Protection Proprietary Technology Adversely Affect Uncertainties Related Patents Protection Proprietary Technology Products Distributed
United States United States Securities Exchange Washington 20549 Form 10-k
United States8221 Unregistered Sales Equity Securities Proceeds
Unresolved Staff Comments Valuation Long-lived Intangible Assets
Valuation Qualifying Accounts Vascular Preservation Services
Violation Government Regulations Result Loss Revenues Customers Additional Violation Government Regulations Result Loss Revenues Customers Well
Voting Procedures Vote Required Waiver Compliance
Waivers Code Waivers Indemnification
Webcast Conference Call Information Welcome Further Dialogue Open Negotiation
Wells Fargo Credit Agreement William Northrup
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki